Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $29 | $15 | $10 | $10 |
| Short-Term Investments | $19 | $0 | $0 | $0 |
| Receivables | $6 | $0 | $0 | $0 |
| Inventory | $5 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $12 | $5 | $1 |
| Total Curr. Assets | $61 | $27 | $15 | $11 |
| Property Plant & Equip (Net) | $8 | $47 | $38 | $13 |
| Goodwill | $0 | $3 | $3 | $3 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | -$50 | -$42 | -$16 |
| Total NC Assets | $9 | $50 | $42 | $16 |
| Other Assets | $0 | $19 | $13 | $12 |
| Total Assets | $70 | $96 | $70 | $40 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $15 | $23 | $4 | $6 |
| Total Curr. Liab. | $17 | $25 | $5 | $7 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $0 | $0 | $0 |
| Other Liabilities | $0 | $32 | $36 | $11 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $18 | $60 | $44 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$333 | -$240 | -$203 | -$180 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $385 | $275 | $228 | $198 |
| Total Equity | $52 | $36 | $25 | $19 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $70 | $96 | $70 | $40 |
| Net Debt | -$28 | -$15 | -$10 | -$10 |